Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ingovax acwy
- Development stage
- Phase 3
- Lead developer
- Incepta Pharmaceuticals
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Ingovax ACWY is a quadrivalent meningococcal polysaccharide vaccine developed by Incepta Pharmaceuticals in Bangladesh for the prevention of invasive meningococcal disease. It is designed to provide active immunization against *Neisseria meningitidis* serogroups A, C, W-135, and Y. The vaccine is administered via subcutaneous injection and contains purified capsular polysaccharides from each of the four targeted serogroups. In clinical trials conducted by icddr,b, Ingovax ACWY was evaluated for immunogenicity and safety in healthy adults, demonstrating non-inferiority to existing quadrivalent meningococcal vaccines like Quadri Meningo. It represents the first meningococcal vaccine to be locally manufactured in Bangladesh.
- Brand names
- Ingovax ACWY
- Other names
- Meningococcal ACWY vaccineIncepta Meningococcal ACWY vaccine
02
Targets
Neisseria meningitidis group C capsular polysaccharideNmA CPS (Neisseria meningitidis group A capsular polysaccharide)Group Y CPS (Neisseria meningitidis group Y capsular polysaccharide)MenW CPS (Neisseria meningitidis serogroup W capsular polysaccharide)
Beyond the preview
Go deeper on ingovax acwy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ingovax acwy.